5 Best Weight Loss Stocks To Invest In

3. Amgen, Inc. (NASDAQ:AMGN)

Number of Hedge Fund Holders: 57

Amgen, Inc. (NASDAQ:AMGN) is another biotech company on our list. It develops an experimental weight-loss hormone, Leptin, which is proving successful in decreasing users’ appetite to aid weight loss.

Our hedge fund data shows 57 hedge funds long Amgen, Inc. (NASDAQ:AMGN) in the second quarter. Their total stake value was $1.6 billion.

Michael Yee at Jefferies maintains a Buy rating and a $310 price target on Amgen, Inc. (NASDAQ:AMGN) as of August 14.

Follow Amgen Inc (NASDAQ:AMGN)